Free Trial

BlackRock Capital Allocation Term Trust (NYSE:BCAT) Short Interest Up 73.5% in September

BlackRock Capital Allocation Term Trust logo with Manufacturing background

Key Points

  • Short interest in BlackRock Capital Allocation Term Trust (NYSE:BCAT) increased by 73.5% in September, rising to 226,600 shares as of September 15th.
  • The company's stock price decreased by 0.3% to $14.90, with a twelve-month low of $12.91 and a high of $16.65.
  • A monthly dividend of $0.2675 per share has been declared, reflecting an annualized yield of 21.5%, payable on October 31st, with the ex-dividend date on October 15th.
  • MarketBeat previews top five stocks to own in November.

BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 226,600 shares, a growth of 73.5% from the August 31st total of 130,600 shares. Based on an average trading volume of 578,200 shares, the days-to-cover ratio is presently 0.4 days. Based on an average trading volume of 578,200 shares, the days-to-cover ratio is presently 0.4 days.

BlackRock Capital Allocation Term Trust Stock Down 0.3%

Shares of NYSE:BCAT traded down $0.05 during midday trading on Monday, reaching $14.90. The company's stock had a trading volume of 563,661 shares, compared to its average volume of 535,283. BlackRock Capital Allocation Term Trust has a twelve month low of $12.91 and a twelve month high of $16.65. The stock has a fifty day moving average of $14.92 and a 200 day moving average of $14.75.

BlackRock Capital Allocation Term Trust Cuts Dividend

The company also recently declared a monthly dividend, which will be paid on Friday, October 31st. Investors of record on Wednesday, October 15th will be given a dividend of $0.2675 per share. This represents a c) annualized dividend and a yield of 21.5%. The ex-dividend date is Wednesday, October 15th.

Institutional Trading of BlackRock Capital Allocation Term Trust

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. AdvisorNet Financial Inc grew its position in BlackRock Capital Allocation Term Trust by 83.3% during the second quarter. AdvisorNet Financial Inc now owns 1,947 shares of the company's stock valued at $29,000 after buying an additional 885 shares during the period. Geneos Wealth Management Inc. lifted its holdings in BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company's stock valued at $31,000 after purchasing an additional 1,582 shares in the last quarter. Noble Wealth Management PBC purchased a new position in BlackRock Capital Allocation Term Trust during the first quarter valued at $32,000. Red Tortoise LLC purchased a new position in BlackRock Capital Allocation Term Trust during the second quarter valued at $33,000. Finally, NBC Securities Inc. lifted its holdings in BlackRock Capital Allocation Term Trust by 151,600.0% during the first quarter. NBC Securities Inc. now owns 3,034 shares of the company's stock valued at $43,000 after purchasing an additional 3,032 shares in the last quarter. Institutional investors and hedge funds own 36.12% of the company's stock.

About BlackRock Capital Allocation Term Trust

(Get Free Report)

-

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BlackRock Capital Allocation Term Trust Right Now?

Before you consider BlackRock Capital Allocation Term Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock Capital Allocation Term Trust wasn't on the list.

While BlackRock Capital Allocation Term Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.